Ładuje się......
HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families
We and others recently discovered HHLA2 as a new B7 family member and transmembrane and immunoglobulin domain containing 2 (TMIGD2) as one of its receptors. Based on a new study we propose that HHLA2 may represent a novel immunosuppressive mechanism within the tumor microenvironment and hence could...
Zapisane w:
| Wydane w: | Oncoimmunology |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570140/ https://ncbi.nlm.nih.gov/pubmed/26405587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1026534 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|